Yup. They missed the EBIT. but remembering that last year they only made $1m NPAT, this is not a bad result. Even after the crazy dilution to the shares, they still manage to get 19% increase in EPS.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game